| Human natural killer cell development AG Freud, MA Caligiuri Immunological reviews 214 (1), 56-72, 2006 | 612 | 2006 |
| The broad spectrum of human natural killer cell diversity AG Freud, BL Mundy-Bosse, J Yu, MA Caligiuri Immunity 47 (5), 820-833, 2017 | 547 | 2017 |
| Evidence for discrete stages of human natural killer cell differentiation in vivo AG Freud, A Yokohama, B Becknell, MT Lee, HC Mao, AK Ferketich, ... The Journal of experimental medicine 203 (4), 1033-1043, 2006 | 538 | 2006 |
| A human CD34 (+) subset resides in lymph nodes and differentiates into CD56brightNatural killer cells AG Freud, B Becknell, S Roychowdhury, HC Mao, AK Ferketich, ... Immunity 22 (3), 295-304, 2005 | 479 | 2005 |
| Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells TA Fehniger, K Suzuki, A Ponnappan, JB VanDeusen, MA Cooper, ... The Journal of experimental medicine 193 (2), 219-232, 2001 | 458 | 2001 |
| Location and cellular stages of natural killer cell development J Yu, AG Freud, MA Caligiuri Trends in immunology 34 (12), 573-582, 2013 | 419 | 2013 |
| Interleukin-1β selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue T Hughes, B Becknell, AG Freud, S McClory, E Briercheck, J Yu, C Mao, ... Immunity 32 (6), 803-814, 2010 | 247 | 2010 |
| Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases BM Haverkos, Z Pan, AA Gru, AG Freud, R Rabinovitch, M Xu-Welliver, ... Current hematologic malignancy reports 11, 514-527, 2016 | 191 | 2016 |
| A progenitor cell expressing transcription factor RORγt generates all human innate lymphoid cell subsets SD Scoville, BL Mundy-Bosse, MH Zhang, L Chen, X Zhang, KA Keller, ... Immunity 44 (5), 1140-1150, 2016 | 188 | 2016 |
| Modeling human natural killer cell development in the era of innate lymphoid cells SD Scoville, AG Freud, MA Caligiuri Frontiers in immunology 8, 360, 2017 | 165 | 2017 |
| Human natural killer cell development in secondary lymphoid tissues AG Freud, J Yu, MA Caligiuri Seminars in immunology 26 (2), 132-137, 2014 | 163 | 2014 |
| Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function Y Deng, Y Kerdiles, J Chu, S Yuan, Y Wang, X Chen, H Mao, L Zhang, ... Immunity 42 (3), 457-470, 2015 | 151 | 2015 |
| Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH17 cytokine interleukin-22 T Hughes, B Becknell, S McClory, E Briercheck, AG Freud, X Zhang, ... Blood, The Journal of the American Society of Hematology 113 (17), 4008-4010, 2009 | 144 | 2009 |
| NKp80 defines a critical step during human natural killer cell development AG Freud, KA Keller, SD Scoville, BL Mundy-Bosse, S Cheng, Y Youssef, ... Cell reports 16 (2), 379-391, 2016 | 111 | 2016 |
| Evidence for a stepwise program of extrathymic T cell development within the human tonsil S McClory, T Hughes, AG Freud, EL Briercheck, C Martin, AJ Trimboli, ... The Journal of clinical investigation 122 (4), 1403-1415, 2012 | 111 | 2012 |
| Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma MA Krook, A Lenyo, M Wilberding, H Barker, M Dantuono, KM Bailey, ... Molecular cancer therapeutics 19 (3), 847-857, 2020 | 105 | 2020 |
| The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells T Hughes, EL Briercheck, AG Freud, R Trotta, S McClory, SD Scoville, ... Cell reports 8 (1), 150-162, 2014 | 101 | 2014 |
| CD56 expression marks human group 2 innate lymphoid cell divergence from a shared NK cell and group 3 innate lymphoid cell developmental pathway L Chen, Y Youssef, C Robinson, GF Ernst, MY Carson, KA Young, ... Immunity 49 (3), 464-476. e4, 2018 | 99 | 2018 |
| PRDM1/Blimp-1 controls effector cytokine production in human NK cells MA Smith, M Maurin, HI Cho, B Becknell, AG Freud, J Yu, S Wei, J Djeu, ... The Journal of Immunology 185 (10), 6058-6067, 2010 | 96 | 2010 |
| Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2 S Roychowdhury, KF May Jr, KS Tzou, T Lin, D Bhatt, AG Freud, ... Cancer Research 64 (21), 8062-8067, 2004 | 89 | 2004 |
